Mergers and Acquisitions

Blackstone is about to buy shares of Soho China

American conglomerate Blackstone Group will buy all issued shares worth HKD 23.7 billion ($3.05 billion) in Soho China. This is the largest real estate-related deal in China.

American conglomerate Blackstone Group will buy all issued shares worth HKD 23.7 billion ($3.05 billion) in Soho China. This is the largest real estate-related deal in China.

Read more

The world has one more super rich family

The sale of shares of Medline Industries to a group of companies has made the Mills family in the US one of the wealthiest families in the world.

The sale of shares of Medline Industries to a group of companies has made the Mills family in the US one of the wealthiest families in the world.

Read more

Global mergers and acquisitions hit record high for the third consecutive month

According to Refinitiv data, the total value of pending and completed M&A transactions announced between January and May 2021 reached a record high of $2.4 trillion.

According to Refinitiv data, the total value of pending and completed M&A transactions announced between January and May 2021 reached a record high of $2.4 trillion.

Read more

Amazon acquires Hollywood's famous movie studio for nearly $8.5 billion

Amazon said it would buy MGM Studios for $8.45 billion. The move marks the company's unprecedented bold move into the entertainment industry and fuels its ambitions in the online video space.

Amazon said it would buy MGM Studios for $8.45 billion. The move marks the company's unprecedented bold move into the entertainment industry and fuels its ambitions in the online video space.

Read more

Big deal in the medical industry: AstraZeneca acquires Alexion

AstraZeneca acquires Alexion - a company specializing in immunological diseases.

The acquisition of Alexion gives AstraZenca the edge in a super-profitable business that treats rare disorders.

AstraZeneca acquires Alexion - a company specializing in immunological diseases.

The acquisition of Alexion gives AstraZenca the edge in a super-profitable business that treats rare disorders.

Read more

Copyright © Vuhes. All rights reserved. The Content may not be copied, distributed,  republished, uploaded, posted or transmitted in any way without the prior written consent of Vuhes.